Clinical Cancer Research CR Helping Patients Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Clinical Cancer Research 14, 25, January 1, 2008. doi: 10.1158/1078-0432.CCR-07-0450
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Casalini, P.
Right arrow Articles by Tagliabue, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Casalini, P.
Right arrow Articles by Tagliabue, E.

Human Cancer Biology

Two Distinct Local Relapse Subtypes in Invasive Breast Cancer: Effect on their Prognostic Impact

Patrizia Casalini1, Maria Luisa Carcangiu2, Raija Tammi6, Päivi Auvinen7, Veli-Matti Kosma7,8, Pinuccia Valagussa3, Marco Greco4, Andrea Balsari5, Sylvie Ménard1 and Elda Tagliabue1

Authors' Affiliations: 1 Experimental Oncology, 2 Pathology, 3 Ufficio Operativo, and 4 Department of Surgery, Fondazione IRCCS "Istituto Nazionale dei Tumori", and 5 Institute of Pathology, University of Milan, Milan, Italy, 6 Departments of Biomedicine and Anatomy, University of Kuopio, 7 Department of Oncology and Pathology, Kuopio University Hospital, and 8 Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Kuopio, Kuopio, Finland

Requests for reprints: Sylvie Ménard, Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy. Phone: 39-2239-2571; Fax: 39-2236-2692; E-mail: sylvie.menard{at}istitutotumori.mi.it.

Purpose: Local relapse (LR) remains an important concern in breast cancer surveillance. Given the unique opportunity to study local recurrences in the breast in the absence of irradiation, we tested the possibility of identifying a particular tumor feature that might account for LR.

Experimental Design: Archival specimens from 235 patients belonging to the control arm (no radiotherapy) of the Milan 3 Trial were retrieved and included in this study. H&E-stained histologic slides were reviewed for diagnostic reassessment. A panel of biological variables was assessed by immunohistochemical/cytochemical staining.

Results: Onset of LR was significantly linked only to patient's age, with a hazard ratio (HR) to relapse reduced by 60% in patients >50 years of age (P = 0.002). Univariate and multivariate Cox analyses in women ≤50 years of age indicated that only expression of hyaluronan in tumor cells was associated with LR risk (HR, 2.48; P = 0.0364 and HR, 2.34; P = 0.0580, respectively). In patients >50 years of age, lymph node and estrogen receptor status were significantly predictive of LR (HR, 3.34; P = 0.0113 and HR, 0.39; P = 0.0424, respectively). Multivariate analysis indicated that apart from lymph node positivity (HR, 3.48; P = 0.0120), none of the variables associated with LR in univariate analysis displayed an independent LR-predictive power. LR had a strong prognostic impact on distant metastasis in patients >50 years of age, whereas in younger women, LR did not affect the risk of metastasis.

Conclusions: These results support the notion that LR arises from two distinct mechanisms, one that is more frequent in young patients, associated with host characteristics, and is not linked with prognosis, and another that is less frequent, but is associated with tumor aggressiveness which represents a peculiar and distinct marker of breast tumor malignancy.




This article has been cited by other articles:


Home page
JCOHome page
A. Merlo, P. Casalini, M. L. Carcangiu, C. Malventano, T. Triulzi, S. Menard, E. Tagliabue, and A. Balsari
FOXP3 Expression and Overall Survival in Breast Cancer
J. Clin. Oncol., April 10, 2009; 27(11): 1746 - 1752.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
L. Lusa, B. Peissel, S. Manoukian, E. Marchesi, P. Radice, M. A. Pierotti, and M. Gariboldi
Re: Molecular Basis for Estrogen Receptor {alpha} Deficiency in BRCA1-Linked Breast Cancer
J Natl Cancer Inst, May 21, 2008; 100(10): 752 - 753.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. M. Hosey, J. J. Gorski, J. E. Quinn, W. Y. Chung, A. Mccann, and D. P. Harkin
Response: Re: Molecular Basis for Estrogen Receptor {alpha} Deficiency in BRCA1-Linked Breast Cancer
J Natl Cancer Inst, May 21, 2008; 100(10): 753 - 754.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.